IRTC - BTIG makes top medtech stock picks for 2024 sees sector stabilizing
2023-12-17 17:48:14 ET
More on Abbott Laboratories, Glaukos, etc.
- Abbott Laboratories: A 'Must-Have' In A Defensive Dividend Growth Portfolio
- Zimmer Biomet: Still Many Questions After A Solid Year So Far
- Abbott Laboratories: One Of The Safest Dividend Growth Stocks On The Market
- Glaukos stock jumps 15% on FDA approval of glaucoma drug
- Piper sees GLP-1s increasing demand for knee/hip surgeries near-term
For further details see:
BTIG makes top medtech stock picks for 2024, sees sector stabilizing